Epigenetics as a new therapeutic target for postoperative cognitive dysfunction
Related Experiment Video
Updated: May 15, 2026

A Mouse Model of Orthopedic Surgery to Study Postoperative Cognitive Dysfunction and Tissue Regeneration
Published on: February 27, 2018
Yun Wang1, Zhijun Chen, Yujie Zhao
1Department of Anesthesiology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
Abstract:
Persistent memory and learning disabilities may occur postoperatively and may be related to neurodegenerative processes. Epigenetic dysregulation has been implicated to abnormal brain function and neurodegenerative diseases. Some risk factors contributing to postoperative cognitive disorder (POCD) have been identified, including exposure to general anesthesia, hypotension, hypoxia, psychoactive drugs, hippocampal inflammation induced by the surgical intervention, etc. The current evidence supports these risk factors might induce epigenetic dysfunction in the brain. It is possible that epigenetic regulation might be the common downstream pathway of these risk factors, since the chromatin remodeling is necessary for the memory-associated gene transcription and expression. Here, we present our hypothesis that the epigenetic dysregulation might be a critical mechanism underlying POCD. Our hypothesis may lead to a new therapeutic strategy of epigenetic intervention for POCD.
More Related Videos
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Pharmacogenetics and Pharmacogenomics: Overview

